Literature DB >> 16122487

Clinical experience in 397 consecutive thoracoscopic sympathectomies.

King F Kwong1, Lindsay B Cooper, Leslie A Bennett, Whitney Burrows, Ziv Gamliel, Mark J Krasna.   

Abstract

BACKGROUND: The purpose of this study is to evaluate the safety and efficacy of thoracoscopic sympathectomy for the treatment of hyperhidrosis, blushing, reflex sympathetic dystrophy, and digital ischemia.
METHODS: We conducted a retrospective review of 202 patients who underwent thoracoscopic sympathectomy at the University of Maryland from March 1992 to April 2003.
RESULTS: Three hundred ninety-seven procedures were performed on 202 patients (105 women, 97 men). Mean age was 29 years (range, 9 to 65). Indications for surgery included hyperhidrosis, facial blushing, digital ischemia, and reflex sympathetic dystrophy. Synchronous bilateral sympathectomies were performed in 194 patients; right side alone (n = 6); left side alone (n = 1); 1 patient had staged bilateral sympathectomies. Single incision with lung isolation technique was used. There was no mortality. Preoperative symptoms resolved completely or significantly improved in greater than 90% of patients. One patient with reflex sympathetic dystrophy recurred and 1 patient with hyperhidrosis complained of significant compensatory sweating. Compensatory sweating to a lesser degree occurred in approximately one third of patients. Complications included asymptomatic pleural effusion (n = 1), pneumothorax (n = 1), and reoperation for chylothorax that was identified early (n = 1). In 2 patients treated for facial blushing, Horner's syndrome developed postoperatively; 1 of them subsequently underwent blepharoplasty. In 3 patients, hyperesthesias developed at the incision.
CONCLUSIONS: Thoracoscopic sympathectomy can be performed safely and with excellent results. Compensatory sweating is the main side effect, although significant complaints from this are rare. Horner's syndrome remains an extremely uncommon complication as a result of thoracoscopic sympathectomy at our institution.

Entities:  

Mesh:

Year:  2005        PMID: 16122487     DOI: 10.1016/j.athoracsur.2005.03.076

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Nonintubated transareolar single-port thoracic sympathicotomy with a needle scope in a series of 85 male patients.

Authors:  Jian-Feng Chen; Jian-Bo Lin; Yuan-Rong Tu; Min Lin; Xu Li; Fan-Cai Lai; Quan Du; Yuan-Da Dai
Journal:  Surg Endosc       Date:  2015-10-30       Impact factor: 4.584

Review 2.  Uniportal video-assisted thoracoscopy approach to the management of non-pulmonary diseases of the chest.

Authors:  Ching Yeung; Jennifer Dawson; Sebastien Gilbert
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

3.  Thoracoscopic excision of the sympathetic chain: an easy and effective treatment for hyperhidrosis in children.

Authors:  Mohamed Sameh Shalaby; Ehab El-Shafee; Hesham Safoury; Sameh Abd El Hay
Journal:  Pediatr Surg Int       Date:  2011-09-30       Impact factor: 1.827

4.  Effect of lowering or restricting sympathectomy levels on compensatory sweating.

Authors:  Songwang Cai; Shaohong Huang; Jun An; Yun Li; Yimin Weng; Hongying Liao; Huiguo Chen; Libao Liu; Jinyuan He; Junhang Zhang
Journal:  Clin Auton Res       Date:  2014-04-17       Impact factor: 4.435

Review 5.  The correlation between the method of sympathetic ablation for palmar hyperhidrosis and the occurrence of compensatory hyperhidrosis: a review.

Authors:  Doron Kopelman; Moshe Hashmonai
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

6.  Surgical treatment of facial blushing: Patient selection and operative technique (retrospective observational study).

Authors:  Jae Kil Park; Kwanyong Hyun; Mi Hyoung Moon; Jungsun Lee
Journal:  Medicine (Baltimore)       Date:  2022-07-08       Impact factor: 1.817

7.  Surgical treatment of compensatory hyperhidrosis: Retrospective observational study.

Authors:  Mi Hyoung Moon; Kwanyong Hyun; Jae Kil Park; Jungsun Lee
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.